Abstract: An AI-enabled health monitoring and recovery support device for ocular region, comprises of a hemispherical wearable body 101 to be worn on a user’s cranial region, an imaging unit 102 integrated with a hyperspectral analysis module to determine spatial orientation and corneal axis, a speaker 107 to emit audio prompt, issuing verbal confirmation commands through a microphone 108, the HUD 105 to display a sequence of variably scaled alphanumeric characters, a pair of extendable hollow conduits 109 each terminating in an electronically controlled sprayer 110 where the imaging unit 102 is configured to detect anomalies, a silicone member 112 for removing debris from the user’s ocular surface, an annular shaped structure 115 to dynamically expand in response to an eyelid obstruction condition, a silicone padded effector 120 for effective removal of the foreign particle, a Peltier unit 128 and iris lids 129 to release the gel and cooling mask’s surface.
Description:FIELD OF THE INVENTION
[0001] The present invention relates to an AI-enabled health monitoring and recovery support device for ocular region that is capable of detecting the dryness in the user’s eyes and taking necessary steps to alleviate the dryness symptoms for improving user comfort and preventing irritation or damage to the eyes.
BACKGROUND OF THE INVENTION
[0002] A health monitoring and recovery support for the ocular region is essential due to the increasing prevalence of eye-related conditions caused by factors such as digital eye strain, aging, and environmental stressors. Continuous monitoring of ocular health allows for early detection of issues like dry eye, glaucoma, or retinal disorders, which is critical for timely intervention and prevention of vision loss. Additionally, recovery support features, such as controlled temperature therapy, gentle massage, or hydration, significantly aid in relieving eye fatigue, reducing inflammation, and accelerating healing after surgeries or treatments.
[0003] Traditional methods of health monitoring and recovery support for the ocular region include routine eye check-ups, manual symptom reporting, use of eye drops, warm compresses, cold masks, and rest. These methods, though helpful, often lack real-time monitoring, consistency, and personalized care, making them less effective for early diagnosis and continuous recovery management. Traditional methods for ocular health support are limited by their reliance on patient self-reporting and scheduled check-ups, which delay early detection of issues. They lack real-time data, personalized treatment, and continuous monitoring. This often leads to inconsistent care, missed symptoms, and less effective recovery, especially for chronic or post-surgical eye conditions.
[0004] US9770169B2 discloses systems and methods for monitoring eye health. The systems and methods monitor eye health by measuring scleral strain by way of an implantable monitor, a wearable monitor configured in eyeglasses, or an external monitor using a portable tablet computing device. Certain embodiments of the strain monitor may be utilized to measure the strain on any surface to which it is attached, including, but not limited to, the skin of a patient or the surface of a structure such as a building or a bridge.
[0005] US20110307041A1 discloses an eye pack for evaporative cooling of the face proximate to one or more eyes is provided. In one aspect, an eye pack is disclosed comprising a gelatinous foam impregnated with an aqueous solution of polyvinyl alcohol embedded therein, and a barrier affixed to at least one side of the foam, wherein the barrier allows transfer of heat and restricts the transfer of the solution. In another aspect, a cooling eye pack, includes a gelatinous material including glycerin, a hydrophilic polymer, water, at least one paraben, and any one or more of Ethylene diamine tetra acetic acid tetra sodium salt and ethylene diamine tetra acetic acid disodium salt; and a head securement adapted to secure the eye pack to a face proximate to one or more eyes of a human.
[0006] Conventionally, many devices have been developed for monitoring health and supporting the recovery for ocular region but they lack in detecting the dryness in the user’s eyes to alleviate the dryness symptoms for improving user comfort. These existing devices also lack in detecting the presence of foreign particles in the eye of the user for removing the particles.
[0007] In order to overcome the aforementioned drawbacks, there exists a need in the art to develop a device that requires to be capable of detecting the dryness in the user’s eyes to alleviate the dryness symptoms for improving user comfort and preventing irritation or damage to the eyes and detecting presence of foreign particles in the eye of the user for removing the particles for preventing the discomfort and harmful effects on the eyes.
OBJECTS OF THE INVENTION
[0008] The principal object of the present invention is to overcome the disadvantages of the prior art.
[0009] An object of the present invention is to develop a device that is capable of detecting the dryness in the user’s eyes and taking the necessary steps to alleviate the dryness symptoms for improving user comfort and preventing irritation or damage to the eyes.
[0010] Another object of the present invention is to develop a device that is capable of detecting the presence of foreign particles in the eye of the user and taking the necessary steps for removing the particles, thereby preventing the discomfort and harmful effects on the eyes.
[0011] Yet another object of the present invention is to develop a device that is capable of providing localized cooling therapy to the user’s eye to alleviate periocular swelling, thereby enhancing ocular comfort and supporting overall eye health.
[0012] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.
SUMMARY OF THE INVENTION
[0013] The present invention relates to an AI-enabled health monitoring and recovery support device for ocular region that is capable of detecting the presence of foreign particles in the eye of the user and taking the necessary steps for removing the particles, thereby preventing the discomfort and harmful effects on the eyes.
[0014] According to an embodiment of the present invention, an AI-enabled health monitoring and recovery support device for ocular region, comprises of a hemispherical wearable body developed to be worn on a user’s cranial region, a computing unit wirelessly linked with the body for enabling a user to input commands pertaining to real-time ocular health monitoring and diagnostics routines, an artificial intelligence-based imaging unit integrated with a hyperspectral analysis module and paired with a processor is installed on the body for capturing and processing a sequence of high-resolution ocular images in real time to determine spatial orientation and corneal axis of the user based on reflection geometry and spectral signature differentials from corneal surface of the user’s eye, an extendable rod disposed on the wearable body, and mechanically linked with a transparent optical sheet having an integrated HUD (heads-up display) based on detection of the corneal axis, the microcontroller activates the rod and a motorized ball and socket joint integrated in between the rod and body for allowing a multi-axis adjustment and dynamic positioning of the sheet in orthogonal alignment with the corneal axis of the user’s eyes, a speaker installed on the body for producing audio signals to emit audio prompt instructing the user to initiate a vision assessment by issuing verbal confirmation commands through a microphone operatively installed on the body, upon receipt the initiation commands the microcontroller activates the HUD to display a sequence of variably scaled alphanumeric characters and focal targets towards the user’s visual field while the displayed sequence is dynamically adjusted in position and size based on a pre-programmed diagnostic protocol and the microphone is configured to receive the user’s verbal responses in real-time, a pair of extendable hollow conduits arranged on lateral extremities of the body each terminating in an electronically controlled sprayer where the imaging unit is configured to detect anomalies including but not limited to dryness, foreign particle presence, redness, or swelling, and in event of detection of a dryness condition, the microcontroller is configured to activate the conduit for extending to position the sprayer in alignment with the user’s eyes, in view of enabling the sprayer to spray a fluid stored in a vessel configured with the sprayers in a controlled mist form directly into the user’s ocular region to alleviate the dryness symptoms.
[0015] According to another embodiment of the present invention, the device further comprises of a conical silicone member mounted on the body via an extendable L-shaped link integrated with a motorized hinge joint upon detection of ocular debris by the imaging unit the microcontroller activates the link and hinge joint to impart controlled articulation to the silicone member for removing the debris from the user’s ocular surface, an expandable annular shaped structure installed on the body by means of an extendable L-shaped shaft linked with a motorized pivot joint for providing controlled movement to the structure to circumferentially align with the user’s eye where the structure is configured to dynamically expand in response to an eyelid obstruction condition detected during the debris removal thereby facilitating in mechanical opening of the eye to enable unhindered access for the silicone member and if the identified debris is in a desiccated state the microcontroller is further operable to activate an electronically controlled nozzle mounted on the link for dispensing an appropriate amount of water stored in a receptacle configured with the nozzle into the user’s eye, to hydrate the debris for effective and smooth removal, a silicone padded effector installed on the body via an extendable pole coupled with a motorized hinge the pole being configured to extend and position the effector in direct alignment with the detected foreign particle where the hinge is adapted to precisely control the effector for effective removal of the detected foreign particle from the user’s ocular surface, a motorized roller assembly integrated with a Peltier module disposed with the body through an extendable L-shaped bar for extending/retracting to move the roller in direct contact with the user’s ocular region for providing localized cooling therapy to alleviate periocular swelling, ocular activity post pre-defined rest, a dual-segmented under-eye mask mounted on the body and housed with a reservoir stored with gel, a Peltier unit and motorized iris lids the lids being selectively actuated to release the gel in a controlled manner while the Peltier unit simultaneously cools the mask’s surface, a plurality of multicolour LED arrays embedded in the transparent sheet for projecting wavelength-specific light to regulate the user’s sleep-wake cycle, a temperature sensor that continuously monitors the roller’s and mask’s temperature and dynamically regulate the cooling output to maintain a therapeutic temperature range to ensure effective cooling is provided on the user’s ocular region, the microcontroller is further configured to utilize multiple machine learning protocols trained on user-specific ocular health data, to autonomously adjust therapy parameters, such as spray volume, cooling duration, and diagnostic display sequences, for personalized ocular rehabilitation and a battery is associated with the device for powering up electrical and electronically operated components.
[0016] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.
BRIEF DESCRIPTION OF THE DRAWINGS
[0017] These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
Figure 1 illustrates an isometric view of an AI-enabled health monitoring and recovery support device for ocular region.
DETAILED DESCRIPTION OF THE INVENTION
[0018] The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.
[0019] In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.
[0020] As used herein, the singular forms “a,” “an,” and “the” designate both the singular and the plural, unless expressly stated to designate the singular only.
[0021] The present invention relates to an AI-enabled health monitoring and recovery support device for ocular region that is capable of providing localized cooling therapy to the user’s eye to alleviate periocular swelling, thereby enhancing ocular comfort and supporting overall eye health.
[0022] Referring to Figure 1, an isometric view of an AI-enabled health monitoring and recovery support device for ocular region is illustrated, comprising a hemispherical wearable body 101 developed to be worn on a user’s cranial region, an artificial intelligence-based imaging unit 102 is installed on the body 101, an extendable rod 103 disposed on the wearable body 101, a transparent optical sheet 104 having an integrated HUD (heads-up display) 105, a motorized ball and socket joint 106 integrated in between the rod 103 and body 101, a speaker 107 installed on the body 101, a microphone 108 installed on the body 101, a pair of extendable hollow conduits 109 arranged on lateral extremities of the body 101 each terminating in an electronically controlled sprayer 110, a vessel 111 configured with the sprayers 110.
[0023] Figure 1 further illustrates a conical silicone member 112 mounted on the body 101 via an extendable L-shaped link 113 integrated with a motorized hinge joint 114, an expandable annular shaped structure 115 installed on the body 101 by means of an extendable L-shaped shaft 116 linked with a motorized pivot joint 117, an electronically controlled nozzle 118 mounted on the link 113, a receptacle 119, a silicone padded effector 120 installed on the body 101 via an extendable pole 121 coupled with a motorized hinge 122, a motorized roller assembly 123 integrated with a Peltier module 124 disposed with the body 101 through an extendable L-shaped bar 125, a dual-segmented under-eye mask 126 mounted on the body 101 and housed with a reservoir 127, a Peltier unit 128 and motorized iris lids 129, a plurality of multicolour LED arrays 130 embedded in the transparent sheet 104.
[0024] The device disclosed herein employs a hemispherical wearable body 101 developed to be worn on a user’s cranial region. This body 101 is typically constructed from material that include but not limited to high-strength materials such as reinforced steel or durable aluminum alloys, which provide a robust and resilient enclosure capable of withstanding physical impacts and environmental stressors. The body 101 is furnished with a cushioned cover which helps the user to maintain comfort during the prolong use.
[0025] For activating the device, the user needs to press a push button which is arranged on the body 101 which in turn activates all the related components for performing the desired task. After pressing the button, a closed electrical circuit is formed and current starts to flow that powers an inbuilt microcontroller to allow all the linked components to perform their respective task upon actuation.
[0026] A user interface is installed in a computing unit wirelessly linked with the body 101, for enabling a user to input commands pertaining to real-time ocular health monitoring and diagnostics routines. The user input commands through the keyboard or touch interactive display panel of the computing unit that is transmitted to the microcontroller through a communication module. The communication module includes, but not limited to Wi-Fi (Wireless Fidelity) module, Bluetooth module, GSM (Global System for Mobile Communication) module. The Wi-Fi module contains transmitters and receivers that use radio frequency signals to transmit data wirelessly to the microcontroller. The wireless module typically includes components such as antennas, amplifiers, and processors to facilitate communication and further connected to networks such as Wi-Fi, Bluetooth, or cellular networks, allowing devices to exchange information over short or long distances. The microcontroller linked with a processing unit of the computing unit for interpreting the input commands.
[0027] Upon interpretation of the input command, an artificial intelligence-based imaging unit 102 integrated with a hyperspectral analysis module and paired with a processor, is installed on the body 101 for capturing and processing a sequence of high-resolution ocular images in real time to determine the spatial orientation and corneal axis of the user based on reflection geometry and spectral signature differentials from corneal surface of the user’s eye. The imaging unit 102 comprises of an image capturing arrangement including a set of lenses that captures multiple images in vicinity of the body 101, and the captured images are stored within a memory of the imaging unit 102 in form of an optical data. The imaging unit 102 also comprises of the processor that is integrated with artificial intelligence protocols, such that the processor processes the optical data and extracts the required data from the captured images.
[0028] The hyperspectral analysis module operates by capturing and decomposing light reflected from the user’s corneal surface into a wide range of contiguous spectral bands across the electromagnetic spectrum, often extending from visible to near-infrared wavelengths. This high spectral resolution detects subtle differences in the reflection geometry and spectral signature caused by the unique curvature, moisture content, and refractive properties of the cornea. Internally, the module consists of a dispersive element, such as a tunable filter, coupled with a 2D detector array that spatially resolves each wavelength band. As ocular images are continuously captured in real-time, each spectral pixel (or voxel) is analyzed for the intensity and wavelength-dependent behavior.
[0029] The processor then interprets these rich spectral datasets to construct a multidimensional spectral profile of the cornea, enabling precise determination of spatial orientation and corneal axis by correlating spectral anomalies and reflectance shifts to geometric distortions and angular positioning. This process leverages advanced protocols, including principal component analysis and spectral un-mixing, to isolate relevant features from background noise, ensuring accurate and non-invasive eye tracking and axis estimation. The microcontroller processes the received data and evaluates the spatial orientation and corneal axis of the user based on reflection geometry and spectral signature differentials from the corneal surface of the user’s eye. The imaging unit 102 is configured to differential between dry and wet ocular particles, using hyperspectral data from the imaging unit 102, for optimized removal sequences involving water-based loosening.
[0030] An extendable rod 103 is disposed on the wearable body 101. This extendable rod 103 is mechanically linked with a transparent optical sheet 104 having an integrated HUD (heads-up display) 105. Based on detection of the corneal axis, the microcontroller activates the rod 103 and a motorized ball and socket joint 106, integrated in between the rod 103 and body 101 for allowing a multi-axis adjustment and dynamic positioning of the sheet 104 in orthogonal alignment with the corneal axis of the user’s eyes. The extendible rod 103 operates using a telescopic assembly that allows to change length dynamically while maintaining structural integrity. The rod 103 typically consists of interlocking segments that slide within each other which utilizes a pneumatic unit for the operation.
[0031] The pneumatic unit for extension and retraction operates using compressed air to drive a piston inside a cylinder. When air is supplied to one side of the piston, it creates pressure that pushes the piston rod outward, causing extension. To retract, air is supplied to the opposite side while the initial chamber is vented, pulling the piston rod back. The motorized ball and socket joint 106 enables precise rotational movement in multiple directions by integrating an electric motor. The ball, typically attached to a shaft, fits into the socket, allowing it to rotate freely around several axes. The motor is responsible for rotating the ball within the socket, providing controlled movement along different planes.
[0032] For producing audio signals, a speaker 107 is installed on the body 101. This speaker 107 is used to emit audio prompt instructing the user to initiate a vision assessment. The speaker 107 works by converting the electrical signal into the audio signal. The speaker 107 consists of a cone known as a diaphragm attached to a coil-shaped wire placed between two magnets. When the electric signal is passed through the voice coil, a varying magnetic field is generated by the coil that interacts with the magnet causing the diaphragm to move back and forth. The movement of the diaphragm pushes and pulls air creating sound waves just like the electrical signal received and used to emit the audio prompt.
[0033] The vision assessment is initiated by issuing verbal confirmation commands through a microphone 108 operatively mounted on the body 101. The microphone 108 processes the voice command from the user for securing the clamp over the chair’s armrest by converting sound waves into electrical signals. The signals are analog in nature. These analog signals are then digitized using an analog-to-digital converter (ADC) for further processing. The digital data undergoes pre-processing, including noise reduction and filtering, to improve clarity by eliminating background noise. The cleaned signal is passed for speech recognition powered by artificial intelligence, which analyzes the input to detect keywords or phrases. Once recognized, the microcontroller maps the command and triggers the verbal confirmation commands.
[0034] Upon receipt the initiation commands, the microcontroller activates the HUD 105 to display a sequence of variably scaled alphanumeric characters and focal targets towards the user’s visual field, while the displayed sequence is dynamically adjusted in position and size based on a pre-programmed diagnostic protocol, and the microphone 108 is configured to receive the user’s verbal responses in real-time, thereby facilitating evaluation of visual acuity and bifocal convergence function. The HUD 105 functions by projecting scaled alphanumeric characters and focal targets into the user’s visual field using a micro-display, collimating optics, and a semi-transparent combiner. Upon receiving initiation commands, the microcontroller activates the HUD 105 and runs a diagnostic protocol that adjusts the position, size, and depth of the visuals in real-time. These variations simulate different viewing distances to assess visual acuity and bifocal convergence. The display parameters are dynamically controlled to ensure clarity and alignment with the user’s gaze, while ambient lighting is compensated through brightness adjustments. Simultaneously, the microphone 108 captures the user’s verbal responses for immediate evaluation.
[0035] On the lateral extremities of the body 101, a pair of extendable hollow conduits 109 are arranged, each terminating in an electronically controlled sprayer 110. The imaging unit 102 is configured to detect anomalies including but not limited to dryness, foreign particle presence, redness, or swelling. On detection of a dryness condition, the microcontroller is configured to activate the conduit 109 for extending to position the sprayer 110 in alignment with the user’s eyes, in view of enabling the sprayer 110 to spray a fluid stored in a vessel 111 configured with the sprayers 110, in a controlled mist form directly into the user’s ocular region to alleviate the dryness symptoms. The electronically controlled sprayer 110 is connected to the miniature fluid reservoir via the microfluidic channel embedded within the extendable hollow conduit 109. At the sprayer’s core, a piezoelectric module is used to generate a fine, controlled mist. When activated, the sprayer 110 draws fluid from the reservoir, and the actuator rapidly vibrates the nozzle to break the liquid into micron-sized droplets.
[0036] A conical silicone member 112 is mounted on the body 101 via an extendable L-shaped link 113 that is integrated with a motorized hinge joint 114. Upon detection of ocular debris by the imaging unit 102, the microcontroller activates the link 113 and hinge joint 114 to impart controlled articulation to the silicone member 112 for removing the debris from the user’s ocular surface. The extendable L-shaped link 113 works in the similar manner as the extendable rod 103 by utilizing the pneumatic unit as mentioned above. The hinge joint 114 consists of two interlocking metal leafs connected by a pin, enabling the movement in a controlled manner. The hinge joint 114 works by restricting movement to a single plane while ensuring stability thereby imparting the controlled articulation to the silicone member 112 for removing the debris from the user’s ocular surface.
[0037] Upon removal of the debris from the user’s ocular surface, an expandable annular shaped structure 115 is positioned on the body 101 by means of an extendable L-shaped shaft 116 linked with a motorized pivot joint 117, for providing controlled movement to the structure 115 to circumferentially align with the user’s eye. The extendable L-shaped shaft 116 operates by utilizing the pneumatic unit as mentioned above. The structure 115 is configured to dynamically expand in response to an eyelid obstruction condition detected during the debris removal, thereby facilitating in mechanical opening of the eye, to enable unhindered access for the silicone member 112.
[0038] If the identified debris is in a desiccated state, the microcontroller is further operable to activate an electronically controlled nozzle 118 mounted on the link 113 for dispensing an appropriate amount of water stored in a receptacle 119 configured with the nozzle 118 into the user’s eye. The electronic nozzle 118 for dispensing precisely controls the flow of water using electronically actuated valves and sensor. The nozzle 118 typically consists of a solenoid that regulates the opening and closing of the nozzle 118 based on input signals. This allows for highly accurate and consistent dispensing an appropriate amount of water into the user’s eye, to hydrate the debris for effective and smooth removal.
[0039] A silicone padded effector 120 is mounted on the body 101 via an extendable pole 121 coupled with a motorized hinge 122. The pole 121 is configured to extend and position the effector 120 in direct alignment with the detected foreign particle. The extendable pole 121 works in the similar manner as the extendable rod 103 by utilizing the pneumatic unit as explained above for the extension. The hinge 122 is adapted to precisely control the effector 120 for effective removal of the detected foreign particle from the user’s ocular surface, as coordinated by the microcontroller based on the spatial imaging data of the user’s eye. The hinge’s motion is synchronized with the pneumatic extension of the pole 121, allowing the effector 120 to approach the eye with minimal disturbance. The soft silicone pad gently contacts the ocular surface under force-limited control, and the hinge 122 makes micro-adjustments to assist in dislodging and removing the detected foreign particle safely.
[0040] A motorized roller assembly 123 is integrated with a Peltier module 124 that is disposed with the body 101 through an extendable L-shaped bar 125. The L-shaped bar 125 is used for extending/retracting to move the roller in direct contact with the user’s ocular region for providing localized cooling therapy to alleviate periocular swelling, ocular activity post pre-defined rest. The Peltier module 124 provides a cooling effect using the thermoelectric principle based on the Peltier effect. This module 124 consists of a thermoelectric module (TEM) made of semiconductor materials arranged between two ceramic plates. When the electric current flows through the module 124, it creates a temperature difference, causing one side to absorb heat (cooling effect) while the other side releases heat (heating effect). The motorized roller having the Peltier module 124 integrates an electric motor within the cylinder for providing localized cooling therapy. When powered, the motor generates rotational force, which drives the roller. They operate using alternating current (AC) motors and controlled individually or in groups for precise movement and speed regulation for providing localized cooling therapy to alleviate periocular swelling, ocular activity post pre-defined rest.
[0041] On the body 101, a dual-segmented under-eye mask 126 is mounted and housed with a reservoir 127 stored with gel, a Peltier unit 128 and motorized iris lids 129. The Peltier unit 128 works in the similar manner as the Peltier module 124 explained above. The iris lid operates using a series of interlinked, overlapping blades that open and close in a circular motion. The motor in the iris lid drives a mechanical linkage that synchronously moves the blades apart, creating an opening for the gel to pass through. The lids 129 are selectively actuated to release the gel in a controlled manner while the Peltier unit 128 simultaneously cools the mask’s surface, thereby providing precision-targeted therapy to the user’s under-eye region, for ensuring effective recovery of the user’s ocular regions.
[0042] Each of the Peltier module 124 and Peltier unit 128 is linked with a temperature sensor. The temperature sensor continuously monitors the rollers and mask’s temperature and dynamically regulates the cooling output to maintain a therapeutic temperature range to ensure effective cooling is provided on the user’s ocular region. This sensor is typically a thermistor positioned in close proximity to the surface of the roller and mask 126. The sensor continuously measures the temperature by detecting changes in electrical resistance. These readings are transmitted to the microcontroller, which interprets them to assess whether the current temperature is within the therapeutic range. If deviations are detected, the microcontroller adjusts the current supplied to the Peltier elements, modulating their heat-pumping effect accordingly.
[0043] The microcontroller regulates the actuation of the under-eye mask 126 and the roller assembly 123, in coordination with a pre-programmed diagnostic routine stored in a linked database, which tailors the treatment based on stored medical history and user-specific ocular metrics. With the transparent sheet 104, a plurality of multicolour LED arrays 130 are embedded, for projecting wavelength-specific light to regulate the user’s sleep-wake cycle in response to detected or scheduled requirements, calculated by the device’s body’s usage and imaging unit’s capturing abilities. Each LED array consists of individually addressable diodes capable of emitting light in specific spectral ranges, selected for their physiological impact on melatonin production and alertness.
[0044] The microcontroller is further configured to utilize multiple machine learning protocols trained on user-specific ocular health data, to autonomously adjust therapy parameters, such as spray volume, cooling duration, and diagnostic display sequences, for personalized ocular rehabilitation. The machine learning protocols utilized by the microcontroller are designed to enable adaptive, user-specific ocular therapy by analyzing and learning from historical and real-time ocular health data. These protocols include supervised learning models trained on datasets comprising user-specific parameters such as eye moisture levels, blink patterns, redness frequency, previous diagnoses, and therapy outcomes.
[0045] For supplying power to electrical and electronically operated components, a battery is associated with the device. The battery powers electrical and electronic components by converting stored chemical energy into electrical energy. The battery’s terminals provide a voltage difference, allowing current to flow through circuits that supplies consistent energy to actuate and operate components like motors, sensors and microcontrollers, ensuring seamless functionality.
[0046] The present invention works best in the following manner, where the hemispherical wearable body 101 as disclosed in the invention is developed to be worn on the user’s cranial region where the user interface is installed in the computing unit wirelessly linked with the body 101 for enabling the user to input commands pertaining to real-time ocular health monitoring and diagnostics routines. The microcontroller linked with the processing unit of the computing unit for interpreting the input commands to trigger the artificial intelligence-based imaging unit 102 integrated with the hyperspectral analysis module and paired with the processor is installed on the body 101 for capturing and processing the sequence of high-resolution ocular images in real time to determine spatial orientation and corneal axis of the user based on reflection geometry and spectral signature differentials from corneal surface of the user’s eye. The imaging unit 102 is configured to differential between dry and wet ocular particles using hyperspectral data from the imaging unit 102 for optimized removal sequences involving water-based loosening. The extendable rod 103 having an integrated HUD (heads-up display) 105, where based on detection of the corneal axis, the microcontroller activates the rod 103 and the motorized ball and socket joint 106, integrated in between the rod 103 and body 101 for allowing the multi-axis adjustment and dynamic positioning of the sheet 104 in orthogonal alignment with the corneal axis of the user’s eyes. The speaker 107 for producing audio signals to emit audio prompt instructing the user to initiate the vision assessment by issuing verbal confirmation commands through the microphone 108. Upon receipt the initiation commands, the microcontroller activates the HUD 105 to display the sequence of variably scaled alphanumeric characters and focal targets towards the user’s visual field, while the displayed sequence is dynamically adjusted in position and size based on a pre-programmed diagnostic protocol and the microphone 108 is configured to receive the user’s verbal responses in real-time. The pair of extendable hollow conduits 109, each terminating in the electronically controlled sprayer 110 where the imaging unit 102 is configured to detect anomalies including but not limited to dryness, foreign particle presence, redness, or swelling, and in event of detection of the dryness condition, the microcontroller is configured to activate the conduit 109 for extending to position the sprayer 110 in alignment with the user’s eyes, in view of enabling the sprayer 110 to spray the fluid stored in the vessel 111 configured with the sprayers 110, in the controlled mist form directly into the user’s ocular region to alleviate the dryness symptoms. The conical silicone member 112 mounted via the extendable L-shaped link 113 integrated with the motorized hinge joint 114 where upon detection of ocular debris by the imaging unit 102, the microcontroller activates the link 113 and hinge joint 114 to impart controlled articulation to the silicone member 112 for removing the debris from the user’s ocular surface. The expandable annular shaped structure 115 installed by means of the extendable L-shaped shaft 116 linked with the motorized pivot joint 117 for providing controlled movement to the structure 115 to circumferentially align with the user’s eye where the structure 115 is configured to dynamically expand in response to the eyelid obstruction condition detected during the debris removal, thereby facilitating in mechanical opening of the eye, to enable unhindered access for the silicone member 112, and if the identified debris is in a desiccated state, the microcontroller is further operable to activate the electronically controlled nozzle 118 for dispensing the appropriate amount of water stored in the receptacle 119 configured with the nozzle 118 into the user’s eye to hydrate the debris for effective and smooth removal.
[0047] In continuation, the silicone padded effector 120 installed via the extendable pole 121 coupled with the motorized hinge 122 where the pole 121 is configured to extend and position the effector 120 in direct alignment with the detected foreign particle where the hinge 122 is adapted to precisely control the effector 120 for effective removal of the detected foreign particle from the user’s ocular surface, as coordinated by the microcontroller based on the spatial imaging data of the user’s eye. The motorized roller assembly 123 integrated with the Peltier module 124 is disposed through the extendable L-shaped bar 125 for extending/retracting to move the roller in direct contact with the user’s ocular region for providing localized cooling therapy to alleviate periocular swelling, ocular activity post pre-defined rest where the dual-segmented under-eye mask 126 housed with the reservoir 127 stored with gel, the Peltier unit 128 and motorized iris lids 129, the lids 129 being selectively actuated to release the gel in the controlled manner while the Peltier unit 128 simultaneously cools the mask’s surface, thereby providing precision-targeted therapy to the user’s under-eye region for ensuring effective recovery of the user’s ocular regions. The temperature sensor monitors the roller’s and mask’s temperature and dynamically regulate the cooling output to maintain the therapeutic temperature range to ensure effective cooling is provided on the user’s ocular region. The microcontroller regulates actuation of the under-eye mask 126 and the roller assembly 123 in coordination with a pre-programmed diagnostic routine stored in the linked database which tailors the treatment based on stored medical history and user-specific ocular metrics. The plurality of multicolour LED arrays 130 for projecting wavelength-specific light to regulate the user’s sleep-wake cycle in response to detected or scheduled requirements calculated by the device’s body’s usage and imaging unit’s capturing abilities. The microcontroller is further configured to utilize multiple machine learning protocols trained on user-specific ocular health data to autonomously adjust therapy parameters, such as spray volume, cooling duration, and diagnostic display sequences, for personalized ocular rehabilitation.
[0048] Although the field of the invention has been described herein with limited reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention. , Claims:1) An AI-enabled health monitoring and recovery support device for ocular region, comprising:
i) a hemispherical wearable body 101 developed to be worn on a user’s cranial region, wherein a user interface is installed in a computing unit wirelessly linked with said body 101, for enabling a user to input commands pertaining to real-time ocular health monitoring and diagnostics routines;
ii) a microcontroller linked with a processing unit of said computing unit for interpreting said input commands to trigger an artificial intelligence-based imaging unit 102 integrated with a hyperspectral analysis module, and paired with a processor, is installed on said body 101 for capturing and processing a sequence of high-resolution ocular images in real time to determine spatial orientation and corneal axis of said user based on reflection geometry and spectral signature differentials from corneal surface of said user’s eye;
iii) an extendable rod 103 disposed on said wearable body 101, and mechanically linked with a transparent optical sheet 104 having an integrated HUD (heads-up display) 105, wherein based on detection of said corneal axis, said microcontroller activates said rod 103 and a motorized ball and socket joint 106, integrated in between said rod 103 and body 101 for allowing a multi-axis adjustment and dynamic positioning of said sheet 104 in orthogonal alignment with said corneal axis of said user’s eyes;
iv) a speaker 107 installed on said body 101 for producing audio signals to emit audio prompt instructing said user to initiate a vision assessment by issuing verbal confirmation commands through a microphone 108 operatively installed on said body 101, wherein upon receipt said initiation commands, said microcontroller activates said HUD 105 to display a sequence of variably scaled alphanumeric characters and focal targets towards said user’s visual field, while said displayed sequence is dynamically adjusted in position and size based on a pre-programmed diagnostic protocol, and said microphone 108 is configured to receive said user’s verbal responses in real-time, thereby facilitating evaluation of visual acuity and bifocal convergence function;
v) a pair of extendable hollow conduits 109 arranged on lateral extremities of said body 101, each terminating in an electronically controlled sprayer 110, wherein said imaging unit 102 is configured to detect anomalies including but not limited to dryness, foreign particle presence, redness, or swelling, and in event of detection of a dryness condition, said microcontroller is configured to activate said conduit 109 for extending to position said sprayer 110 in alignment with said user’s eyes, in view of enabling said sprayer 110 to spray a fluid stored in a vessel 111 configured with said sprayers 110, in a controlled mist form directly into said user’s ocular region to alleviate said dryness symptoms;
vi) a conical silicone member 112 mounted on said body 101 via an extendable L-shaped link 113 integrated with a motorized hinge joint 114, wherein upon detection of ocular debris by said imaging unit 102, said microcontroller activates said link 113 and hinge joint 114 to impart controlled articulation to said silicone member 112 for removing said debris from said user’s ocular surface;
vii) an expandable annular shaped structure 115 installed on said body 101 by means of an extendable L-shaped shaft 116 linked with a motorized pivot joint 117, for providing controlled movement to said structure 115 to circumferentially align with said user’s eye, wherein said structure 115 is configured to dynamically expand in response to an eyelid obstruction condition detected during said debris removal, thereby facilitating in mechanical opening of said eye, to enable unhindered access for said silicone member 112, and if said identified debris is in a desiccated state, said microcontroller is further operable to activate an electronically controlled nozzle 118 mounted on said link 113 for dispensing an appropriate amount of water stored in a receptacle 119 configured with said nozzle 118 into said user’s eye, to hydrate said debris for effective and smooth removal;
viii) a silicone padded effector 120 installed on said body 101 via an extendable pole 121 coupled with a motorized hinge 122, said pole 121 being configured to extend and position said effector 120 in direct alignment with said detected foreign particle, wherein said hinge 122 is adapted to precisely control said effector 120 for effective removal of said detected foreign particle from said user’s ocular surface, as coordinated by said microcontroller based on said spatial imaging data of said user’s eye; and
ix) a motorized roller assembly 123 integrated with a Peltier module 124, disposed with said body 101 through an extendable L-shaped bar 125, for extending/retracting to move said roller in direct contact with said user’s ocular region for providing localized cooling therapy to alleviate periocular swelling, ocular activity post pre-defined rest, wherein a dual-segmented under-eye mask 126, mounted on said body 101 and housed with a reservoir 127 stored with gel, a Peltier unit 128 and motorized iris lids 129, said lids 129 being selectively actuated to release said gel in a controlled manner while said Peltier unit 128 simultaneously cools said mask’s surface, thereby providing precision-targeted therapy to said user’s under-eye region, for ensuring effective recovery of said user’s ocular regions.
2) The device as claimed in claim 1, wherein said imaging unit 102 is configured to differential between dry and wet ocular particles, using hyperspectral data from said imaging unit 102, for optimized removal sequences involving water-based loosening.
3) The device as claimed in claim 1, wherein a plurality of multicolour LED arrays 130 embedded in said transparent sheet 104 for projecting wavelength-specific light to regulate said user’s sleep-wake cycle in response to detected or scheduled requirements, calculated by said device’s body’s usage and imaging unit’s capturing abilities.
4) The device as claimed in claim 1, wherein each of said Peltier module 124 and Peltier unit 128 is linked with a temperature sensor that continuously monitors said roller’s and mask’s temperature and dynamically regulate said cooling output to maintain a therapeutic temperature range to ensure effective cooling is provided on said user’s ocular region.
5) The device as claimed in claim 1, wherein said microcontroller regulates actuation of said under-eye mask 126 and said roller assembly 123, in coordination with a pre-programmed diagnostic routine stored in a linked database, which tailors treatment based on stored medical history and user-specific ocular metrics.
6) The device as claimed in claim 1, wherein said microcontroller is further configured to utilize multiple machine learning protocols trained on user-specific ocular health data, to autonomously adjust therapy parameters, such as spray volume, cooling duration, and diagnostic display sequences, for personalized ocular rehabilitation.
7) The device as claimed in claim 1, wherein a battery is associated with said device for powering up electrical and electronically operated components associated with said device.
| # | Name | Date |
|---|---|---|
| 1 | 202541037735-STATEMENT OF UNDERTAKING (FORM 3) [18-04-2025(online)].pdf | 2025-04-18 |
| 2 | 202541037735-REQUEST FOR EXAMINATION (FORM-18) [18-04-2025(online)].pdf | 2025-04-18 |
| 3 | 202541037735-REQUEST FOR EARLY PUBLICATION(FORM-9) [18-04-2025(online)].pdf | 2025-04-18 |
| 4 | 202541037735-PROOF OF RIGHT [18-04-2025(online)].pdf | 2025-04-18 |
| 5 | 202541037735-POWER OF AUTHORITY [18-04-2025(online)].pdf | 2025-04-18 |
| 6 | 202541037735-FORM-9 [18-04-2025(online)].pdf | 2025-04-18 |
| 7 | 202541037735-FORM FOR SMALL ENTITY(FORM-28) [18-04-2025(online)].pdf | 2025-04-18 |
| 8 | 202541037735-FORM 18 [18-04-2025(online)].pdf | 2025-04-18 |
| 9 | 202541037735-FORM 1 [18-04-2025(online)].pdf | 2025-04-18 |
| 10 | 202541037735-FIGURE OF ABSTRACT [18-04-2025(online)].pdf | 2025-04-18 |
| 11 | 202541037735-EVIDENCE FOR REGISTRATION UNDER SSI(FORM-28) [18-04-2025(online)].pdf | 2025-04-18 |
| 12 | 202541037735-EVIDENCE FOR REGISTRATION UNDER SSI [18-04-2025(online)].pdf | 2025-04-18 |
| 13 | 202541037735-EDUCATIONAL INSTITUTION(S) [18-04-2025(online)].pdf | 2025-04-18 |
| 14 | 202541037735-DRAWINGS [18-04-2025(online)].pdf | 2025-04-18 |
| 15 | 202541037735-DECLARATION OF INVENTORSHIP (FORM 5) [18-04-2025(online)].pdf | 2025-04-18 |
| 16 | 202541037735-COMPLETE SPECIFICATION [18-04-2025(online)].pdf | 2025-04-18 |